We are live on ! Find out more
CLOS

Compagnie Lombard Odier SCmA Portfolio holdings

AUM $9.25B
1-Year Est. Return 27.04%
This Fund
S&P 500
This Quarter Est. Return
+9.36%
1 Year Est. Return
+27.04%
3 Year Est. Return
+108.78%
5 Year Est. Return
+129.43%
10 Year Est. Return
+503.05%
AUM
$4.55B
AUM Growth
+$12.4M
Cap. Flow
-$345M
Cap. Flow %
-7.59%
Top 10 Hldgs %
40.84%
Holding
720
New
73
Increased
111
Reduced
146
Closed
92

Top Buys

Rank Stock Value
1
CRM icon
Salesforce
CRM
+$46.3M
2
BLK icon
Blackrock
BLK
+$25.5M
3
SE icon
Sea Limited
SE
+$21.7M
4
NOW icon
ServiceNow
NOW
+$21.2M
5
EL icon
Estee Lauder
EL
+$19M

Sector Composition

Rank Sector Weight
1 Technology 19.67%
2 Communication Services 18.56%
3 Financials 15.44%
4 Consumer Discretionary 14.23%
5 Healthcare 14.15%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LIT icon
301
Global X Lithium & Battery Tech ETF
LIT
$1.6B
$247K 0.01%
3,400
+1,500
+79% +$96.5K
F icon
302
Ford
F
$55.1B
$245K 0.01%
+16,500
New +$219K
FNV icon
303
Franco-Nevada
FNV
$45.5B
$245K 0.01%
1,681
CALY
304
Callaway Golf Company
CALY
$3.13B
$245K 0.01%
+7,250
New +$233K
HII icon
305
Huntington Ingalls Industries
HII
$12.9B
$240K 0.01%
1,140
-225
-16% -$47.9K
WEN icon
306
Wendy's
WEN
$1.42B
$239K 0.01%
+10,225
New +$235K
ETSY icon
307
Etsy
ETSY
$7.66B
$238K 0.01%
+1,158
New +$214K
OMC icon
308
Omnicom Group
OMC
$23.1B
$237K 0.01%
2,960
DNLI icon
309
Denali Therapeutics
DNLI
$3.98B
$235K 0.01%
3,000
AKAM icon
310
Akamai
AKAM
$16.8B
$233K 0.01%
2,000
BABA icon
311
CALL
Alibaba
BABA
$308B
$233K 0.01%
9,500
GTBP icon
312
GT Biopharma
GTBP
$11.6M
$233K 0.01%
+500
New +$208K
CIT
313
DELISTED
CIT Group Inc.
CIT
$232K 0.01%
4,504
ALLY icon
314
Ally Financial
ALLY
$13.3B
$229K 0.01%
4,595
EMR icon
315
Emerson Electric
EMR
$88.2B
$227K 0.01%
2,356
VMC icon
316
Vulcan Materials
VMC
$36.8B
$226K 0.01%
1,300
-700
-35% -$125K
MS icon
317
Morgan Stanley
MS
$341B
$225K ﹤0.01%
2,466
+1,666
+208% +$143K
ARKF icon
318
ARK Blockchain & Fintech Innovation ETF
ARKF
$764M
$224K ﹤0.01%
4,150
+300
+8% +$15.3K
NVAX icon
319
Novavax
NVAX
$1.28B
$223K ﹤0.01%
1,050
-65,852
-98% -$12.1M
ENLV icon
320
Enlivex Ltd
ENLV
$34.5M
$220K ﹤0.01%
1,667
USIG icon
321
iShares Broad USD Investment Grade Corporate Bond ETF
USIG
$17.3B
$218K ﹤0.01%
+3,600
New +$215K
KKR icon
322
KKR & Co
KKR
$91.5B
$214K ﹤0.01%
+3,615
New +$201K
IEMG icon
323
iShares Core MSCI Emerging Markets ETF
IEMG
$155B
$210K ﹤0.01%
+3,139
New +$207K
BDX icon
324
Becton Dickinson
BDX
$48.1B
$209K ﹤0.01%
882
+574
+186% +$138K
PLAY icon
325
Dave & Buster's
PLAY
$348M
$209K ﹤0.01%
5,147

Similar funds

Compagnie Lombard Odier SCmA's Q2 2021 Portfolio in Review

As of Q2 2021, Compagnie Lombard Odier SCmA held 720 positions worth $4.55B, up 0.27% from $4.54B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Compagnie Lombard Odier SCmA withdrew a net $345M in Q2 2021, closing 92 positions and reducing 146 holdings. Its most notable exit was Allogene Therapeutics, an estimated $18.9M position sold in full.

By sector, the portfolio is most concentrated in Technology at 20% of assets, up from 16% a quarter earlier, followed by Communication Services and Financials.

Against the trend, Compagnie Lombard Odier SCmA opened a new position in Bilibili worth $9.73M.

  • Compagnie Lombard Odier SCmA's largest Q2 2021 buy was Bilibili: 79,851 shares worth $9.73M.
  • Compagnie Lombard Odier SCmA added most to Salesforce in Q2 2021, an estimated $46.3M increase.
  • Compagnie Lombard Odier SCmA's biggest Q2 2021 reduction was Intellia Therapeutics, cutting an estimated $22M.
  • Compagnie Lombard Odier SCmA fully exited Allogene Therapeutics in Q2 2021, selling an estimated $18.9M.
  • Compagnie Lombard Odier SCmA's ten largest holdings make up 41% of its $4.55B portfolio in Q2 2021.
  • Compagnie Lombard Odier SCmA opened 73 new positions and closed 92 in Q2 2021.
  • Compagnie Lombard Odier SCmA's portfolio value rose 0.27% quarter-over-quarter to $4.55B.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2021, filed 15 Jul 2021.